Back
Ultragenyx Pharmaceutical Vs. Quanex Building Products Industry Stock Comparison
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
60.16
Seasonality Move:
-6.93%
Sell
34
NX
Quanex Building Products
Last Price:
27.55
Seasonality Move:
3.11%
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.74. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Quanex Building Products (NX)
is a Sell
Is Quanex Building Products a Buy, Sell or Hold?
- The current Quanex Building Products [NX] share price is $27.52. The Score for NX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
NX Stock Price Chart
What is Quanex Building Products's stock price today?
-
The Quanex Building Products share price today is $27.52
The current trend is relatively stagnant and NX is experiencing slight buying pressure.
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.98 | Buy |
| Relative Strength Index (14 RSI): | 70.9 | Buy |
| Chaikin Money Flow: | -82333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.8 - 57.62) | Buy |
| Bollinger Bands (100): | (39.65 - 51.81) | Buy |
NX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 49.66 | Sell |
| Chaikin Money Flow: | 41750 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.06 - 28.34) | Buy |
| Bollinger Bands (100): | (27.22 - 33.1) | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.53 | Buy |
| 20-day SMA: | 56.2 | Buy |
| 50-day SMA: | 50.15 | Buy |
| 200-day SMA: | 46.03 | Buy |
| 8-day EMA: | 56.94 | Buy |
| 20-day EMA: | 55.44 | Buy |
| 50-day EMA: | 51.48 | Buy |
| 200-day EMA: | 46.26 | Buy |
NX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.78 | Buy |
| 20-day SMA: | 27.31 | Buy |
| 50-day SMA: | 28.65 | Sell |
| 200-day SMA: | 31.79 | Sell |
| 8-day EMA: | 26.98 | Buy |
| 20-day EMA: | 27.34 | Buy |
| 50-day EMA: | 28.41 | Sell |
| 200-day EMA: | 30.13 | Sell |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Quanex Building Products Earnings Growth & NX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.34 per share, and an increase next year of $0.35 per share.
Ultragenyx Pharmaceutical Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Quanex Building Products Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||